At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 7:22:02 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 3 | 3 |
| Avg. Estimate | 0.01 | 0.01 | 0.03 | 0.16 |
| Low Estimate | -0.03 | 0 | -0.15 | 0.08 |
| High Estimate | 0.05 | 0.02 | 0.14 | 0.31 |
| Year Ago EPS | 0.11 | 0.04 | 0.55 | 0.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 5 | 5 |
| Avg. Estimate | 28.67M | 30.5M | 121.46M | 123.69M |
| Low Estimate | 26.6M | 30.07M | 119.4M | 110.4M |
| High Estimate | 29.93M | 31M | 122.71M | 131.2M |
| Year Ago Sales | 32.98M | 32.45M | 152.07M | 121.46M |
| Sales Growth (year/est) | -13.07% | -6.01% | -20.13% | 1.84% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -0.01 | 0.02 | 0 |
| EPS Actual | 0.11 | 0.04 | 0.02 | 0.03 |
| Difference | -- | 0.05 | 0 | 0.03 |
| Surprise % | -- | 500.00% | 19.98% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.01 | 0.01 | 0.03 | 0.16 |
| 7 Days Ago | 0.01 | 0.02 | 0.03 | 0.19 |
| 30 Days Ago | 0.01 | 0.02 | 0.03 | 0.19 |
| 60 Days Ago | 0.01 | 0.02 | 0.03 | 0.19 |
| 90 Days Ago | 0.01 | 0.03 | 0.03 | 0.19 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 2 | -- | 1 | 1 |
| Down Last 30 Days | 2 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ASRT | -87.88% | -75.00% | -94.55% | 422.23% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Initiated | Maxim Group: Buy | 7/26/2024 |
| Initiated | HC Wainwright & Co.: Buy | 7/3/2024 |
| Initiated | Alliance Global Partners: Buy | 5/28/2024 |
| Maintains | Lake Street: Buy to Buy | 3/12/2024 |
| Maintains | BWS Financial: Buy to Buy | 11/3/2023 |
Related Tickers
ORGO Organogenesis Holdings Inc.
3.4000
-3.68%
SIGA SIGA Technologies, Inc.
6.18
+0.49%
EBS Emergent BioSolutions Inc.
8.48
-2.42%
AKBA Akebia Therapeutics, Inc.
1.8500
+1.65%
ETON Eton Pharmaceuticals, Inc.
12.35
+1.56%
SCYX SCYNEXIS, Inc.
1.1400
+2.70%
CYTH Cyclo Therapeutics, Inc.
0.5799
-2.54%
RMTI Rockwell Medical, Inc.
2.0400
-1.45%
OGI Organigram Holdings Inc.
1.4800
-1.99%
DVAX Dynavax Technologies Corporation
12.96
-0.23%